Indivior Pharmaceuticals, Inc. INDV Enterprise value

Enterprise value at other companies

Collegium Pharmaceutical, Inc.COLL

$1.03B+23.1%

Aquestive Therapeutics, Inc.AQST

$460.11M+65.5%

AlkermesALKS

$9.79B+123%

TRV

Trevi Therapeutics, Inc.TRVI

$1.51B+157%

Emergent BiosolutionsEBS

$879.68M+13.9%

FAQ

What is Indivior Pharmaceuticals, Inc.'s enterprise value?

Indivior Pharmaceuticals, Inc. (INDV) reported enterprise value of $4.05B in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s enterprise value changed year-over-year?

Indivior Pharmaceuticals, Inc.'s enterprise value increased by 241.5% year-over-year, from $1.19B to $4.05B.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s enterprise value?

Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s enterprise value has grown at a 51.7% compound annual growth rate (CAGR), from $2.02B to $4.64B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.